Recent Headlines
Young Women Beat Heart Attack
What could have killed them truly has made them stronger. Three Chicago-area survivors of a rare cause of heart attack called spontaneous coronary artery dissection (SCAD) will host the first-ever gathering of SCAD survivors worldwide the weekend of May 4-6, 2012. - April 24, 2012 - SCAD Research Inc
ICRC-Weyer Launch New Social Media Pages
ICRC-Weyer GmbH, a contract research organization (CRO) based in Berlin, Germany, has launched new corporate pages on the world’s leading social networks, Facebook and Google Plus. The company intends to take a pioneering role within the clinical research community by interacting with a global audience and sharing insights with the next generation of clinical research professionals. - April 21, 2012 - ICRC-Weyer GmbH
Fertility Preservation Network Adds Pittsburgh Fertility Preservation Program
Program extends access to Testicular Tissue Cryopreservation, as well as additional Fertility Preservation options. - April 18, 2012 - ReproTech, LLC
TTC Data Shows India Experiencing Sustained Growth in Commercial Clinical Trial Activity
India, with the world's largest pool of clinically ill patients, has more than 500,000 English-speaking doctors, many trained in the United States or the United Kingdom. India has experienced sustained growth in commercial clinical trials, and will soon become the world's third largest... - April 15, 2012 - TTC LLC
TTC a Clinical Trial Organization Standard of Care™ Database Tracks 1.2 Billion Claims Annually
Web-Accessible Standard of Care™ Provides Objective Data on How Sites, Actually Treat Patients Within the Standard of Care - April 13, 2012 - TTC LLC
Flexeffect Presents Scientifically Proven Facial Exercises to Get Rid of Undereye Circles and Other Signs of Aging
FlexEffect Facialbuilding is promoting the Third Edition of its facial exercises program, which features techniques backed by new scientific research. - April 07, 2012 - Flex Effect - Facial Exercises
Higher Springtime UV Radiation Identified in Northern Europe
Based on a multi-year EU-funded study (EuroSun), the International Prevention Research Institute (iPRI) in Lyon, has concluded that UV radiation in Europe appears earlier in the year and farther north than originally believed. Data gathered between 1988 and 1992 demonstrates that in spring, parts... - April 06, 2012 - International Prevention Research Institute
ICRC-Weyer to Adjust Services Portfolio in Light of New European Health Claim Regulations
The German based contract research organization, ICRC-Weyer GmbH, has adjusted its services portfolio in order to meet new requirements for the European nutrition market. With the recent fundamental changes for health claims on dietary supplement product labels, manufacturers will have to invest in research and development. But only specialized CROs are able to manage the new challenge. - April 06, 2012 - ICRC-Weyer GmbH
Colorado BioScience Association Appoints Four Industry Leaders to Board of Directors
Four industry executives were named to the Colorado BioScience Association (CBSA) Board of Directors at its 2012 Annual All-Member Meeting. New CBSA director appointments include James Chomas, Ph.D., Founder & CEO, Surefire Medical; Scott Deeter, President & CEO, Ventria Bioscience; Brent Fassett, Partner, Cooley LLP; and Kerry Ingalls, Vice President of Colorado Operations, Amgen. - April 05, 2012 - Colorado BioScience Association
Dr. Birgit Schoeberl to Discuss Using Mathematical Models to Set Design Criteria for Antibody-Based Therapies in Rosa’s "Impact" World-Wide Webinar Series
Dr. Schoeberl will present “Using Mathematical Models To Set Design Criteria For Antibody-Based Therapies” April 17, 2012. - April 04, 2012 - Rosa & Co LLC
U.S. Granted Patent 8,088,385 B2 Strengthens Advanced Cancer Therapeutics’ Anti-Cancer Product Portfolio
Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, today announced that it has been granted U.S. Patent 8,088,385 B2 titled “PFKFB3 inhibitor for the treatment of a Proliferative Cancer” by the United States Patent... - April 04, 2012 - Advanced Cancer Therapeutics
Rosa to Present Two Lectures at the European Foundation of Medicinal Chemists Conference
Rosa to Present The MQM Standard and Lead Optimization Using Systems Pharmacology Modeling - April 01, 2012 - Rosa & Co LLC
Nanoindentation Instrumentation for the First Time Under $30K
Nanovea announced the arrival of the N3 line dedicated to providing high-end measurement technology to the broader market. Nanovea has fully automated their measurement techniques while designing to price in the $20K market. - March 31, 2012 - NANOVEA
Investing in Health Pays Off - Nicaragua
The Roberto Clemente Health Clinic’s Annual Health Care Fair on February 4 was a success, with numbers far surpassing expectations. Around 1,200 residents, who live in the remote communities of southwest Nicaragua, received free health care in Limon 1, Tola, Rivas. Adults patiently waited to... - March 30, 2012 - The Roberto Clemente Health Clinic
Hometown Urgent Care Opens in Latonia Kentucky
Hometown Urgent Care and WorkCare Center will open in the Latonia Center in front of Kroger. - March 29, 2012 - Hometown Urgent Care
Rosa to Present Systems Pharmacology Workshop at 3rd Annual World PK/PD Summit
Rosa Workshop Presents the MQM Quality Standard for Mechanistic Modeling - March 26, 2012 - Rosa & Co LLC
ImpactRx Acquires AlphaDetail
Addition of AlphaDetail’s global custom market research expertise enhances and expands company’s solutions offerings. - March 25, 2012 - ImpactRx, Inc
Rosa to Present at 2012 Keystone Symposia: Advances in Islet Biology
Modeling analysis enables development of biomarkers for beta cell mass. - March 24, 2012 - Rosa & Co LLC
ALS Therapy Development Institute Announces Eighth Annual "The Cure Is Coming" 5k and Awareness Walk
Participants walk, ride or race to raise money and awareness to end ALS (Lou Gehrig's disease) - March 21, 2012 - ALS Therapy Development Institute
Detroit R&D and ALPCO Diagnostics Sign Distribution Agreement
ALPCO Diagnostics and Detroit R&D agree to a distribution partnership in North America. - March 20, 2012 - ALPCO
Colorado BioScience Association Commends PhRMA and We Work For Health for Showcasing the Critical Importance of Clinical Trials to Chronic Disease Sufferers in the State
Members of Colorado BioScience Association (CBSA) today joined with colleagues from both the public and private sectors, including Colorado Governor John Hickenlooper, at a State Capitol News Conference to applaud the release of PhRMA's new report: “Research in Your Backyard.” Colorado's biopharmaceutical industry assists sufferers of chronic disease and includes approximately 300 companies employing over 5,410 with average salaries of $93,000. - March 19, 2012 - Colorado BioScience Association
Fitzsimons Redevelopment Authority Names New President & CEO
Following an extensive national search, Fitzsimons Redevelopment Authority (FRA) has named Steve VanNurden as its new President & CEO. VanNurden, a seasoned leader in the life science/bioscience space, comes to FRA from Mayo Clinic in Rochester, Minnesota. - March 16, 2012 - Fitzsimons Redevelopment Authority
FEECO Australia Celebrates One Year
FEECO International’s Australia branch is celebrating its one-year anniversary this March. - March 16, 2012 - Feeco International Australia
Dr. Joga Gobburu to Discuss the Impact of Pharmacometrics on Drug Approvals in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”
Dr. Gobburu will present “Impact of Pharmacometric Analyses on New Drug Approval and Labelling Decisions” March 20, 2012. - March 16, 2012 - Rosa & Co LLC
Rosa PK/PD Collaboration with Pfizer to be Presented at ASCPT 2012
PK/PD analyses used to support the rationale for therapeutic strategies targeting myostatin pathway. - March 10, 2012 - Rosa & Co LLC
ADHD - Making Strides with the International Brain Research Foundation
It is not uncommon for students to become distracted and bored in school especially when the subject or lecture is not of high interest. However, when these behaviors significantly interfere with academic performance or result in conduct problems, parents and teachers become frustrated. Often such... - March 09, 2012 - International Brain Research Foundation
RRI Group/Akesis Has Been Part of 60 Dermatology Development Programs
Let RRI Group/Akesis put its Clinical Experience to work for you. RRI Group/Akesis' passion is helping Companies...Grow. - March 08, 2012 - RRI Group/Akesis
IonSense Introduces the DART®-OS Source. Expands Its OpenSpot Mass Spectrometry™ Product Line
OpenSpot® Sample Cards Facilitate Simpler Analysis, Eliminating Most Consumables and Solvents, Reducing Lab Waste. Exhibited at Pittcon 2012. Booth #2609. - March 06, 2012 - IonSense, Inc.
DAVA Oncology, LP- Alexander E. Denes, M.D., F.A.C.P. Joins DAVA Oncology as Medical Director
DAVA Oncology, LP is pleased to announce the addition of Alex Denes, MD as a member of the medical oncology support staff. Dr. Denes is from Washington University School of Medicine, where he currently serves as Associate Professor of Medicine. Dr. Denes has an extensive background as a clinician... - March 03, 2012 - Dava Oncology, LP
Rosa Announces Publication of Its PhysioPD™ Model Qualification Method and Series of Educational Events
Series of Seminars and Workshops to be held in 2012 across the US and in Europe. - March 01, 2012 - Rosa & Co LLC
Mitegen Announces Continued Expansion of Product Lines and Offerings for Crystallographers
Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, recently announced numerous expansions to both their patented product portfolio and to their line of distributed products. - February 25, 2012 - MiTeGen, LLC
Mitegen Announces Distribution Agreement with Mexico Diffractia S. de R.L.de C.V.
Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed a distribution agreement with Mexico Diffractia S. de R.L.de C.V. of... - February 24, 2012 - MiTeGen, LLC
OsoBio Appoints Marian Meyer Director of Labs
Meyer manages the company’s chemistry and microbiology labs, which are responsible for such quality-control services as materials testing and release, environmental monitoring and analytical methods compliance. - February 23, 2012 - OSO BioPharmaceuticals Manufacturing, LLC
FDA Clears ASI’s GenASIs Advanced Imaging for HER-2/neu Analysis
ASI’s GenASIs automated scanning and image analysis system for detection and quantifying chromosome 17 and the HER-2/neu gene has been cleared by the United States Food and Drug Administration (FDA) for marketing in the US. - February 22, 2012 - Applied Spectral Imaging
Biomedica Immunoassays Appoints ALPCO Diagnostics as Its Exclusive Distributor in Canada
ALPCO Diagnostics was recently appointed as Biomedica Immunoassays' exclusive distributor in Canada. - February 15, 2012 - ALPCO
Milton Boyer Named President of OSO BioPharmaceuticals Manufacturing
Boyer has been responsible for guiding business strategies and creating new growth opportunities at OsoBio since 2008 - February 15, 2012 - OSO BioPharmaceuticals Manufacturing, LLC
SFL’s Managing Director to Speak at Healthcare Businesswomen’s Association Event
SFL is pleased to announce that Shayesteh Fürst-Ladani, Managing Director of the company, will be speaking at the upcoming Healthcare Businesswomen’s Association European meeting entitled “The Role of Regulatory Affairs in Successful Development and Launch of Healthcare Products” to be held in Basel, Switzerland. - February 09, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
Biopontis Alliance Fund and Rosa Announce Strategic Relationship for Early Stage Drug Development
Collaboration will combine Rosa’s PhysioPD™ modeling & simulation capabilities with Biopontis’ innovative asset sourcing and financial structure to improve early drug development productivity. - February 07, 2012 - Rosa & Co LLC
Dr. Hartmut Derendorf to Discuss PK/PD-based Drug Development in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”
Dr. Derendorf, will present “PK/PD-based Development of Anti-infective Agents” February 13, 2012. - February 06, 2012 - Rosa & Co LLC
Rosa to Present at 2012 Keystone Symposia: Cancer and Metabolism
Modeling analysis enables understanding efficacy of large numbers of potential drug combinations. - February 03, 2012 - Rosa & Co LLC
Mitutoyo Introduces World’s First 0.1µm Micrometer
Mitutoyo America Corporation introduces the first micrometer to offer 0.1µm resolution measurement. The High-Accuracy Digimatic® Digital Micrometer is available in a convenient, hand-held tool. - February 02, 2012 - Mitutoyo America Corporation
FDA Clears ASI’s GenASIs Advanced Imaging for UroVysion Analysis
GenASIs Scan & Analysis cleared for FISH Detection and Analysis of chromosomal abnormalities in urine specimens. - February 01, 2012 - Applied Spectral Imaging
Advanced Cancer Therapeutics Chief Scientific Officer to Present Preclinical Data on Glycolysis Inhibitors at World Cancer Metabolism Summit
Advanced Cancer Therapeutics, LLC (ACT), a for-profit private company dedicated to bringing new anti-cancer therapies to market, today announced that Dr. Gilles Tapolsky, ACT’s Chief Scientific Officer, has been selected to present at the World Cancer Metabolism Summit to be held February 1 – February 2, 2012 in Washington, D.C. - February 01, 2012 - Advanced Cancer Therapeutics
Roberto Clemente Health Clinic to Host Health Care Fair
Hundreds of residents who live in the remote communities of southwest Nicaragua will receive free healthcare at the Roberto Clemente Health Clinic’s Annual Health Care Fair from 9 a.m. to 2 p.m. on Saturday, February 4, in Limon 1 Tola, Rivas, Nicaragua. A team of more than 30 medical... - January 31, 2012 - The Roberto Clemente Health Clinic
Dr. Mike Reed to Participate in Roundtable Panel of American Society of Phamacometrics
Industry Presenters Will Focus on the Use and Benefits of Physiologic, Mechanistic Models in Drug Development - January 30, 2012 - Rosa & Co LLC
Colorado’s Bioscience Industry Leaders and Legislators Focus on 2012 Initiatives at Annual "BioScience Day at the Capitol"
Colorado BioScience Association (CBSA) is hosting its fourth annual "BioScience Day at the Capitol" on February 2. The CBSA is building upon one of its most successful years in its history, making impressive strides in the areas of industry advocacy, programming, marketing communications, membership and education. - January 30, 2012 - Colorado BioScience Association
Clinical Trials GPS Shares 2011 Q4 Findings; Almost 40% of Trials Aimed at Seniors, Less Than 17% Funded by the Government
Internal data shows a trend towards female participants, a surprisingly low volume of smokers, majority are willing to stay overnight, and an average age of 42. - January 27, 2012 - Clinical Trials Institute
Pfizer and Rosa to Present at 2012 Keystone Symposia: Pathogenesis of Diabetes
Insulin degradation and the mechanisms controlling it have significant impact on glucose homeostasis and diabetes. - January 26, 2012 - Rosa & Co LLC
Clinical Financial Services (CFS) Expands Internationally with Office in Edinburgh, Scotland
Clinical Financial Services, LLC (CFS), a specialty service provider focused on the business and financial management activities for clinical trials, has expanded its global presence by opening a new office in Edinburgh, Scotland. April Mulroney, CA, CPA, having most recently served as Vice... - January 26, 2012 - Clinical Financial Services
Clinical Trials GPS Highlights New Diabetes Trials; Aims to Help the Over 25 Million Individuals in U.S. Affected by Diabetes
25.8 million children and adults in the United States - 8.3% of the population - have diabetes. This equates to $116 billion in direct medical costs, and another $58 billion in indirect costs. - January 25, 2012 - Clinical Trials Institute